Gordian Bio CEO explains how a cutting-edge in v
Author: Michael
Study aims to determine whether MKK4 inhibitor c
Led by figures from Oxford, Genomics England and
Companies join forces to discover and develop ne
Capsida Biotherapeutics announced it has received
Juvena Therapeutics has announced a research coll
Company’s latest product continuously monitors
Neurotech firm Somnee secures funding to scale p
Insilico Medicine has launched Nach01, a new foun
Celularity Inc.